Journal of Maxillofacial and Oral Surgery

, Volume 11, Issue 1, pp 13–20 | Cite as

Comparative Analysis of Intralesional Sclerotherapy with Sodium Tetradecyl Sulfate Versus Bleomycin in the Management of Low Flow Craniofacial Soft Tissue Vascular Lesions

  • Hemant BajpaiEmail author
  • Sarika Bajpai
Comparative Study



Comparison of the efficacy of bleomycin over sodium tetradecyl sulfate (STS) when given intralesionally in the treatment of oral and maxillofacial venous malformation.


16 patients with venous malformation in craniofacial region were randomly divided into two groups of eight. Group 1 was given intralesional injection of bleomycin and group 2 was injected with STS. All the cases were evaluated for a minimum period of two and a maximum of 3 years.


Efficacy of bleomycin was found to be superior to STS, when used as intralesional sclerotherapic agent. Most of the vascular lesions of group 1 resolved after first dose giving a cure rate of 87.5% and no recurrence was observed. Group 2 patients however, required 4–6, a mean of five repeated dosage of intralesional STS before their lesions started to resolve and three patients reported with recurrence within 2 years, giving an overall effective response rate of 62.5%.


Bleomycin under selected conditions appears to be an excellent therapy for treating soft tissue vascular lesions of low flow nature in craniofacial region. Predictable results were obtained with a high success rate. No systemic or pulmonary complications occurred.


Vascular Venous malformation Maxillofacial 


  1. 1.
    Mulliken JB, Glowacki J (1982) Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 69(3):412–422PubMedCrossRefGoogle Scholar
  2. 2.
    Sasaki GH, Pang CY, Wittliff JL (1984) Pathogenesis and treatment of infant skin strawberry hemangiomas: clinical and in vitro studies of hormonal effects. Plast Reconstr Surg 73(3):359–370PubMedCrossRefGoogle Scholar
  3. 3.
    Folkman J, Klagsbrun M (1987) Angiogenic factors. Science 235(4787):442–447PubMedCrossRefGoogle Scholar
  4. 4.
    Yih WY, Ma GS, Merrill RG, Sperry DW (1989) Central hemangioma of the jaws. J Oral Maxillofac Surg 47(11):1154–1160PubMedCrossRefGoogle Scholar
  5. 5.
    Takahashi K, Mulliken JB, Kozakewich HP, Rogers RA, Folkman J, Ezekowitz RA (1994) Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest 93(6):2357–2364PubMedCrossRefGoogle Scholar
  6. 6.
    Johnson PL, Eckard DA, Brecheisen MA, Girod DA, Tsue TT (2002) Percutaneous ethanol sclerotherapy of venous malformations of the tongue. AJNR Am J Neuroradiol 23(5):779–782PubMedGoogle Scholar
  7. 7.
    Rahbar R, McGill T, Mulliken J (2005) Vascular tumors and malformations of the head and neck. In: Cummings CW (ed) Otolaryngology-head and neck surgery. Mosby, Philadelphia, pp 4013–4026Google Scholar
  8. 8.
    Kane WJ, Morris S, Jackson IT et al (1995) Significant hemangiomas and vascular malformations of the head and neck: clinical management and treatment outcomes. Ann Plast Surg 35(2):133–143PubMedCrossRefGoogle Scholar
  9. 9.
    O’Donovan JC, Donaldson JS, Morello FP, Pensler JM, Vogelzang RL, Bauer B (1997) Symptomatic hemangiomas and venous malformations in infants, children, and young adults: treatment with percutaneous injection of sodium tetradecyl sulfate. AJR Am J Roentgenol 169(3):723–729PubMedGoogle Scholar
  10. 10.
    Baurmash H, Mandel L (1963) The nonsurgical treatment of hemangioma with Sotradecol. Oral Surg Oral Med Oral Pathol 16:777–782PubMedCrossRefGoogle Scholar
  11. 11.
    Minkow B, Laufer D, Gutman D (1979) Treatment of oral hemangiomas with local sclerosing agents. Int J Oral Surg 8(1):18–21PubMedCrossRefGoogle Scholar
  12. 12.
    Govrin-Yehudain J, Moscona AR, Calderon N, Hirshowitz B (1987) Treatment of hemangiomas by sclerosing agents: an experimental and clinical study. Ann Plast Surg 18(6):465–469PubMedCrossRefGoogle Scholar
  13. 13.
    Baurmash H, DeChiara S (1991) A conservative approach to the management of orofacial vascular lesions in infants and children: report of cases. J Oral Maxillofac Surg 49(11):1222–1225PubMedCrossRefGoogle Scholar
  14. 14.
    Khandpur S, Sharma VK (2010) Utility of intralesional sclerotherapy with 3% sodium tetradecyl sulphate in cutaneous vascular malformations. Dermatol Surg 36(3):340–360PubMedCrossRefGoogle Scholar
  15. 15.
    Siniluoto TM, Svendsen PA, Wikholm GM, Fogdestam I, Edstrom S (1997) Percutaneous sclerotherapy of venous malformations of the head and neck using sodium tetradecyl sulphate (sotradecol). Scand J Plast Reconstr Surg Hand Surg 31(2):145–150PubMedCrossRefGoogle Scholar
  16. 16.
    Legiehn GM, Heran MK (2008) Venous malformations: classification, development, diagnosis, and interventional radiologic management. Radiol Clin North Am 46(3):545–597PubMedCrossRefGoogle Scholar
  17. 17.
    Acevedo JL, Shah RK, Brietzke SE (2008) Nonsurgical therapies for lymphangiomas: a systematic review. Otolaryngol Head Neck Surg 138(4):418–424PubMedCrossRefGoogle Scholar
  18. 18.
    Muir T, Kirsten M, Fourie P, Dippenaar N, Ionescu GO (2004) Intralesional bleomycin injection (IBI) treatment for haemangiomas and congenital` vascular malformations. Pediatr Surg Int 12(19):766–773CrossRefGoogle Scholar
  19. 19.
    Zheng JW, Zhang ZY, Zhu HG, Wang YA (2006) Przegląd Flebologiczny 14(5):193–209 © Blackhorse Scientific Publishers, 2006Google Scholar
  20. 20.
    Spence J, Krings T, terBrugge KG, da Costa LB, Agid R (2010) Interventional percutaneous sclerotherapy for facial venous malformations: subjective clinical and objective MR imaging follow-up results. Am J Neuroradiol 31:955–960PubMedCrossRefGoogle Scholar
  21. 21.
    Hou R, Guo J, Hu K, Yang Y, Wang L, Kong L, Liu G, Lei D (2010) A clinical study of ultrasound-guided intralesional injection of bleomycin A5 on venous malformation in cervical-facial region in China. J Vasc Surg 51(4):940–945PubMedCrossRefGoogle Scholar
  22. 22.
    Sainsbury DCG, Kessell G, Fall AJ, Muir T (2011) Intralesional bleomycin injection treatment for vascular Birthmarks: a 5-year experience at a single United Kingdom Unit. Plast Reconstr Surg 127(5):2031–2044PubMedCrossRefGoogle Scholar
  23. 23.
    Fonseca RJ (2000) Oral and maxillofacial surgery, vol 5. Philadelphia, W.B. Saunders Company, p 433Google Scholar

Copyright information

© Association of Oral and Maxillofacial Surgeons of India 2011

Authors and Affiliations

  1. 1.Department of Oral & MaxilloFacial SurgeryMaharanapratap Dental College & HospitalKanpurIndia
  2. 2.Aanya Dental & Craniofacial HospitalKanpurIndia

Personalised recommendations